Showing results (71-80 of 160) with videos related to
Sort By:
Pageof 16
The Journal of Clinical Investigation|April 1, 1983
Behavior in vivo of normal and dysfunctional C1 inhibitor in normal subjects and patients with hereditary angioneurotic edemaM Quastel, R Harrison, M Cicardi, et al.Pediatric Research|January 1, 1976
Liver in alpha1-antitrypsin deficiency: morphologic observations and in vitro synthesis of alpha1-antitrypsinA K Bhan, R J Grand, H R Colten, et al.Clinical Immunology and Immunopathology|January 1, 1983
Attachment of [35S]cysteine to the labile site of the third component of complement via the alternative pathwayC J Rutherford, C A Alper, F S Rosen, et al.Annals of Internal Medicine|September 1, 1986
Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typingsD E Craven, Z L Awdeh, L M Kunches, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1978
Evidence for a silent or null gene in hereditary C2 deficiencyK M Pariser, D Raum, E M Berkman, et al.American Journal of Human Genetics|January 1, 1979
Mapping of the structural gene for the second component of complement with respect to the human major histocompatibility complexD Raum, D Glass, C B Carpenter, et al.The Journal of Clinical Investigation|August 1, 1984
Extended major histocompatibility complex haplotypes in type I diabetes mellitusD Raum, Z Awdeh, E J Yunis, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1984
Genetic polymorphism of the sixth component (C6) of rat complementJ Granados, D V Cramer, J B Caputo, et al.Blood|February 1, 1988
Genetically determined polymorphism of the circulating human breast cancer-associated DF3 antigenD F Hayes, H Sekine, D Marcus, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1976
Complement activation in semi-solid medium: Insolubilization of properdin and the third component of complement (C3) in agar gelsJ B Ziegler, L Watson, I Goodkofsky, et al.Pageof 16